BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:08 PM
 | 
Jul 22, 2008
 |  BC Extra  |  Company News

No action on telavancin PDUFA date

Theravance (NASDAQ:THRX) said it has not received an action letter from FDA for an NDA for telavancin to treat complicated skin and skin...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >